Diacomit (Stiripentol)

Diacomit is an anticonvulsant medicine used for the treatment of seizures associated with Dravet syndrome in patients taking clobazam who are aged 6 months and older and weighing 7 kg or more. There is no clinical data to support the use of this pharmaceutical product as monotherapy in Dravet syndrome.

Recommended Dosage: The recommended dosage is 50 mg/kg/day, administered in 2 or 3 divided doses (i.e., 16.67 mg/kg thrice daily or 25 mg/kg twice daily), depending on the patient’s age and body weight. If the exact dosage can not be achieved with available strengths, round to the nearest possible dosage, which is usually within 50-150 mg of the recommended 50 mg/kg/day. A combination of a couple of Diacomit strengths can be used to achieve this dosage. The maximum recommended total dosage is 3,000 mg daily.

Diacomit capsule must be swallowed completely with a glass of water during a meal. Avoid breaking or opening the capsules.

Diacomit Powder for Oral Suspension should be mixed in a glass of water (100mL) and should be taken promptly after mixing during a meal. To be sure there is no drug left in the glass, add a small amount of water (25mL) to the drinking cup and drink all of the mixture. 

Take a missed dose as soon as possible. If it is near time for the very next scheduled dose, take the missed dose. Instead, take the next scheduled dose. Do not double the doses.

• Diacomit 250 mg or 500 mg medication can cause somnolence. Doctors should evaluate patients for somnolence. Doctors should alert patients against engaging in hazardous activities requiring mental alertness, such as operating dangerous machinery or motor vehicles, until the effect of medicine on mental alertness is known.
• Concomitant use of medication Stiripentol with certain other existing CNS depressants, including alcohol, may be responsible for increasing the risk of sedation and somnolence. 
• Stiripentol can cause decreases in appetite and weight. Nausea and vomiting may also occur a bit more frequently in Stiripentol-treated patients. Given the frequency of these side effects, the growth of pediatric patients treated with drug Stiripentol should be carefully monitored.
• The stiripentol capsule can be responsible for causing a significant reduction in neutrophil and platelet count. Hematologic testing needs to be done prior to starting therapy with Stiripentol, and then every six months.
• As with most antiepileptic medicines, Diacomit should generally be withdrawn gradually to reduce the probability of higher seizure frequency and status epilepticus. At junctures where rapid withdrawal of Diacomit is needed (e.g., in the setting of serious side effects), apt monitoring is required.
• Phenylalanine can be hazardous to those with phenylketonuria. Diacomit for oral suspension contains phenylalanine, a component of aspartame. Each 250 mg and 500 mg packet contains 1.40 mg and 2.80 mg phenylalanine respectively. Before prescribing it to a patient with Phenylalanine, consider the combined daily quantity of phenylalanine from entire sources, including Diacomit for oral suspension. Capsules do not contain phenylalanine.
• AEDs, including Diacomit 500mg or 250mg, may increase the risk of suicidal thoughts or behavior in those taking these medicines for any indication. Those treated with any AED for any indication need to be assessed for the emergence or worsening of depression, suicidal thoughts or behavior, or any unusual changes in behavior or mood. Patients should notify their health specialist if they become pregnant or intend to become pregnant during Stiripentol therapy. Encourage patients to enroll in the NAAED Pregnancy registry in case they become pregnant. Patients should notify their health specialist if they are breastfeeding or intend to breastfeed during therapy. 

What documents are required to import DIACOMIT to India?

DIACOMIT (Stiripentol) Capsules can be imported by patients or government hospitals on the name of the patients only. 

The following documentation required to import the product:

• Valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patients Identity Proof (issued by government of India)

How does order be confirmed?

The order will be confirmed only after the receipt of:

• Valid prescription of Doctor
• Import permit if applicable

Is DIACOMIT available in India?

DIACOMIT (Stiripentol Capsules) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is facilitator providing input

• On availability of Diacomit in India (Hyderabad, Mumbai, Kolkata, Chennai, Ahmedabad, Delhi, Bangalore and Pune etc.)
• Medicine Price.
• Finding Genuine and reliable source from Canada, Europe, USA and Australia
• Ensuring 100% transparency.

DIACOMIT can be made available to patients, doctors and hospitals at Delhi, Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Bangalore, Srinagar, Jammu, Jaipur, Noida, Chandigarh, Ludhiana, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.

IPN (Indian Pharma Network) can facilitate the supply of DIACOMIT (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable). 

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Diacomit capsule price in India. 

We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source the DIACOMIT (Cancer Treatment Medicines) from across the globe, and has the ability to supply. Indian Pharma Network offers its customers worldwide access to the best available treatment.

Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Diacomit®?

Stiripentol is Generic Name for the trade name drug Diacomit®.

What is the Manufacturer Name of Diacomit®?

Diacomit® is manufactured by Biocodex. 

Is Diacomit® approved by the FDA?

Yes, Diacomit® is approved by the FDA. Date of first/initial approval: August 20, 2018.

What is the dosage and form of Diacomit® supplied?

Diacomit® is supplied as Capsule and Powder for Oral Suspension in 250 mg/500 mg dosage strength. 

Where can I get Diacomit® at the best price in India?

To get the best diacomit 500 mg/250 mg capsule price in India, contact Indian Pharma Network (WHO-GDP & ISO 9001:2008 authorized Company). A medical prescription is required while buying Diacomit®.

What are the most common side effects with Diacomit®? 

The most common side effects with Diacomit® include: decreased appetite, somnolence, agitation, ataxia, weight decreased, nausea, hypotonia, tremor, dysarthria, and insomnia. 

How much does Diacomit® cost in India?

Diacomit cost in India is reasonable and can vary. In order to procure this Dravet Syndrome medicine authentically, you can Call/WhatsApp: +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Diacomit®?

Store in a dry place at temperature 20-25°C (68-77°F); excursions permitted to 15-30°C (59-86°F). Store in the original package in order to protect from light.

Is it safe to buy Diacomit® online from India? 

Yes, You can buy Diacomit capsule online from India at the best price from Indian Pharma Network if Diacomit® has not been approved or is not available in your country. 

What are the Highlights of prescribing information for Diacomit®?

Click Here to download full  Diacomit prescribing information.